STOCK TITAN

Sofgen Pharma S.A WTS (PRCWF) Debt by Year

PRCWF OTC

Sofgen Pharma S.A WTS carried $41.4M in long-term debt against $30.3M in cash and equivalents at the end of fiscal year 2024. Long-term debt rose 33.1% from the prior fiscal year. The table below carries 6 fiscal years, from 2019 to 2024, and the quarters Sofgen Pharma S.A WTS has filed alongside them.

FY2024 annual
Long-Term Debt $41.4M
Cash & Equivalents $30.3M
YoY +33.1%
5Y CAGR -33.6%
Source SEC Filings Latest period FY2024, ended Dec 31, 2024 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

PRCWF Debt & Cash by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY24FilingFY23FilingFY22FilingFY21FilingFY20FilingFY19Filing
Long-Term Debt$41.4M+33.1%$31.1M+6.7%$29.2M+0.4%$29.0M-91.5%$339.7M+6.0%$320.5M
Cash & Equivalents$30.3M+73.1%$17.5M-59.3%$43.0M-40.4%$72.1M+1605.2%$4.2M+107.1%$2.0M

PRCWF Debt & Cash by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'24FilingQ4'23FilingQ2'23FilingQ4'22FilingQ2'22FilingQ4'21FilingQ4'20FilingQ4'19FilingQ4'18Filing
Long-Term Debt$41.4M+33.1%$31.1M+6.7%$169.6M$29.2M+0.4%N/A$29.0M-91.5%$339.7M+6.0%$320.5M+5.0%$305.2M
Cash & Equivalents$30.3M+73.1%$17.5M-59.3%$11.5M-69.3%$43.0M-40.4%$37.6M$72.1M+1605.2%$4.2M+107.1%$2.0M-28.2%$2.8M

What long-term debt means

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.

More Sofgen Pharma S.A WTS financials

Frequently Asked Questions

Sofgen Pharma S.A WTS carried $41.4M in long-term debt against $30.3M in cash and equivalents at the end of fiscal year 2024.

Sofgen Pharma S.A WTS (PRCWF) long-term debt rose by 33.1% year over year, from $31.1M to $41.4M in fiscal year 2024.

Across the 6 fiscal years this page covers, Sofgen Pharma S.A WTS (PRCWF) long-term debt went from $320.5M in fiscal year 2019 to $41.4M in fiscal year 2024.

Sofgen Pharma S.A WTS (PRCWF) reported $41.4M in long-term debt in Q4 2024. This represents an increase of 33.1% from the same quarter a year earlier.

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Sofgen Pharma S.A WTS (PRCWF) reported on that line in every period on record.